Table 4 Baseline and the incidence of ARDS
Patients | Characteristics | O+P group | O group | P value |
|---|---|---|---|---|
All patients | n = 39 | n = 43 | ||
patients had already got ARDS before received NAIs | n = 3 | n = 7 | ||
Study patients | n = 36 | n = 36 | ||
Age (years): mean (SD) | 52.58(12.70) | 59.31(13.85) | 0.44 | |
No. of male (%) | 24 | 24 | 1.00 | |
Time from symptom onset to NAIs administration (days):median(IQR) | 7.00(4.25, 8.00) | 6.00(4.00,8.00) | 0.57 | |
Viral load(log10 /ul) at day 0: median(IQR) | 4.07(3.00, 4.47) | 3.58(2.89,4.47) | 0.73 | |
APACHE II score: mean(SD) | 19.17(8.28) | 20.22(7.76) | 0.58 | |
New ARDS developed patients (%) | 28(77.78) | 23(63.89) | 0.30 | |